Notes - Segment Information, Etc.

TOWA PHARMACEUTICAL CO.,LTD. - Filing #7252380

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
259,594,000,000 JPY
53,490,000,000 JPY
206,103,000,000 JPY
259,594,000,000 JPY
JPY
227,934,000,000 JPY
178,715,000,000 JPY
49,218,000,000 JPY
JPY
227,934,000,000 JPY
Transactions with other segments
374,000,000 JPY
374,000,000 JPY
JPY
JPY
-374,000,000 JPY
105,000,000 JPY
JPY
105,000,000 JPY
-105,000,000 JPY
JPY
Other items
Depreciation
15,677,000,000 JPY
2,293,000,000 JPY
13,384,000,000 JPY
15,677,000,000 JPY
JPY
13,659,000,000 JPY
11,601,000,000 JPY
2,058,000,000 JPY
JPY
13,659,000,000 JPY
Increase in property, plant and equipment and intangible assets
33,391,000,000 JPY
4,413,000,000 JPY
28,978,000,000 JPY
33,391,000,000 JPY
JPY
35,967,000,000 JPY
33,748,000,000 JPY
2,218,000,000 JPY
JPY
35,967,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.